Skin graft donor sites · Randomized trial · 2010
Does shockwave help the skin heal faster where a graft was taken?
In this trial, one shockwave treatment during surgery helped the area where skin was taken for a graft heal faster: it was at least 95% covered with new skin in about 14 days, compared with about 17 days with standard dressings alone.
Helped skin heal faster than dressings alone- adults having a skin graft after burns or injuries
- 28
- shockwave treatment, during the operation
- 1
- days for all donor sites to heal
- 11–20
Good to know: Pain and scarring were not measured.
Ottomann C, Hartmann B, Tyler J, et al. J Am Coll Surg, 2010 · Read the paper ↗
How this study worked
The treatment
Shockwave + dressings
Shockwave, 1 session
- Sessions
- 1
- Pulses
- 100 per area · each cm² of donor site
- Strength
- 0.1mJ/mm²
- Numbing
- Not mentioned · given during the operation
- Device
- OW 180 C DermaGold
- Everyone also got
- Silicone mesh dressing (Mepitel) and antiseptic gel, changed daily
Compared with: The same daily dressings without shockwave
Settings are what each study used, not a prescription.
Who took part
28 adults who needed a thin skin graft after burns or injuries: 13 had shockwave and 15 standard care.
Side effects
No infection, bleeding, swelling or skin reactions were seen at the donor site in either group.
All the numbers and the full appraisal
The results, in numbers.
28 adults requiring split-thickness grafting for burns or trauma; 13 ESWT and 15 standard care, all analyzed.
Participant counts; outcome-specific denominators remain in each panel.
Participant counts; outcome-specific denominators remain in each panel.
Time to ≥95% epithelialization1 reported outcome
Time to ≥95% epithelialization
Time to ≥95% epithelialization days
| Group | n | Baseline | Follow-up |
|---|---|---|---|
| Shockwave treatment | 13 | — | 13.9 (SD 2) |
| Control | 15 | — | 16.7 (SD 2) |
SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.
Between reported groups
Analysis of variance comparing mean time to epithelialization between the two groups
Primary outcome favored ESWT; trial stopped early.
Analysis details and source
Primary outcome favored ESWT; trial stopped early.
How treatment was delivered
OW 180 C DermaGold, 100 impulses/cm², 0.1 mJ/mm², one intraoperative application, average 13 min; sterile gel/plastic interface. Frequency not stated.
No clinically apparent donor-site infection, bleeding, swelling or adverse skin reaction in either group; no structured CTCAE assessment.
Early stopping can exaggerate benefit; no pain, distress, quality-of-life or cosmetic outcomes measured. Patients and the outcome assessor were blinded; the treating physician knew each patient's allocation. Schaden/Thiele disclosed TRT stock; Schaden board membership. Partial funding came from the Combat Wound Initiative Program and Internationales Zentrum für Stosswellentherapie.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Early stopping can exaggerate benefit; no pain, distress, quality-of-life or cosmetic outcomes measured. Patients and the outcome assessor were blinded; the treating physician knew each patient's allocation. Schaden/Thiele disclosed TRT stock; Schaden board membership. Partial funding came from the Combat Wound Initiative Program and Internationales Zentrum für Stosswellentherapie.
Source-linked critical reading
Randomized trials
Technical source record
Full source read: body, methods, results, all tables and figure captions, discussion and disclosures. External supplements not supplied with local PDF.
The donor skin site closed sooner in this trial, but effects on pain and later scarring remain unknown.
Does one shockwave treatment shorten the time to at least 95% epithelialization of a split-thickness skin-graft donor site?
Randomized trial of 28 adults, 13 receiving shockwave treatment and 15 standard care; recruitment stopped before the planned sample of 54.
28 adults requiring split-thickness grafting for burns or trauma; 13 ESWT and 15 standard care, all analyzed.
Single defocused treatment immediately after skin harvesting, while anesthetized.
Mepitel silicone mesh and polyhexanide/octenidine gel, changed daily in both groups.
The extracted panels retain the original outcome units and assessment times. Time to ≥95% epithelialization was 13.9±2.0 versus 16.7±2.0 days (p=.0001); all donor sites healed within 11–20 days. Study stopped at planned interim analysis after 28 rather than 54 participants.
Time to ≥95% epithelialization was 13.9±2.0 versus 16.7±2.0 days (p=.0001); all donor sites healed within 11–20 days. Study stopped at planned interim analysis after 28 rather than 54 participants.
No clinically apparent donor-site infection, bleeding, swelling or adverse skin reaction in either group; no structured CTCAE assessment.
Early stopping can exaggerate benefit; no pain, distress, quality-of-life or cosmetic outcomes measured. Patients and the outcome assessor were blinded; the treating physician knew each patient's allocation. Schaden/Thiele disclosed TRT stock; Schaden board membership. Partial funding came from the Combat Wound Initiative Program and Internationales Zentrum für Stosswellentherapie.
Result is specific to donor sites receiving this dressing regimen; it does not establish superior cosmetic healing or less pain.
An adequately powered donor-site trial should avoid efficacy-driven early stopping, use blinded closure assessment, and measure pain, scar quality and structured adverse events.
Read the original article.
Prospective Randomized Trial of Accelerated Re-epithelization of Skin Graft Donor Sites Using Extracorporeal Shock Wave Therapy
Ottomann C, Hartmann B, Tyler J, Maier H, Thiele R, Schaden W, Stojadinovic A. · J Am Coll Surg · 2010
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →